Septerna, Inc. Files 8-K on Officer/Director Changes
Ticker: SEPN · Form: 8-K · Filed: Sep 29, 2025 · CIK: 1984086
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes
TL;DR
Septerna's 8-K drops: new execs, director changes, and comp details. Governance shake-up incoming.
AI Summary
On September 25, 2025, Septerna, Inc. filed an 8-K report detailing the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. The filing also includes Regulation FD disclosures and financial statements and exhibits.
Why It Matters
This filing provides crucial updates on Septerna, Inc.'s corporate governance and executive appointments, which can impact investor confidence and strategic direction.
Risk Assessment
Risk Level: medium — Changes in directors and officers, especially if unexpected, can signal underlying issues or strategic shifts that may affect the company's future performance.
Key Numbers
- 001-42382 — SEC File Number (Identifies the company's filing with the SEC.)
- 84-3891440 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Septerna, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- 250 East Grand Avenue, Suite 65, South San Francisco, CA 94080 (address) — Principal Executive Offices
FAQ
What specific changes occurred regarding directors or officers?
The filing indicates the departure of directors or certain officers, the election of directors, and the appointment of certain officers.
What is the date of the earliest event reported in this 8-K?
The earliest event reported is dated September 25, 2025.
What is Septerna, Inc.'s principal executive office address?
Septerna, Inc.'s principal executive office is located at 250 East Grand Avenue, Suite 65, South San Francisco, California 94080.
What are the key items covered in this 8-K filing?
The key items include Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; and Financial Statements and Exhibits.
What is Septerna, Inc.'s SIC code?
Septerna, Inc.'s Standard Industrial Classification (SIC) code is 2834, for Pharmaceutical Preparations.
Filing Stats: 976 words · 4 min read · ~3 pages · Grade level 10.9 · Accepted 2025-09-29 16:31:50
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share SEPN The Nasdaq Stock Mar
- $12,000 — e an additional annual cash retainer of $12,000 for his service as Chair of the R&D Com
Filing Documents
- d942032d8k.htm (8-K) — 29KB
- d942032dex991.htm (EX-99.1) — 10KB
- 0001193125-25-223292.txt ( ) — 156KB
- sepn-20250925.xsd (EX-101.SCH) — 3KB
- sepn-20250925_lab.xml (EX-101.LAB) — 18KB
- sepn-20250925_pre.xml (EX-101.PRE) — 11KB
- d942032d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits 99.1 Press Release issued by Septerna, Inc. on September 29, 2025, furnished herewith. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Septerna, Inc. Date: September 29, 2025 By: /s/ Jeffrey Finer, M.D., Ph.D. Jeffrey Finer, M.D., Ph.D. Chief Executive Officer